Agios Pharmaceuticals
AGIO
#5039
Rank
HK$12.70 B
Marketcap
HK$217.81
Share price
4.28%
Change (1 day)
-39.12%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2025 (TTM): -HK$3.71 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are HK$44.79 Million. In 2024 the company made an earning of -HK$3.32 Billion a decrease over its 2023 earnings that were of -HK$3.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$3.71 Billion11.93%
2024 -HK$3.32 Billion8.75%
2023 -HK$3.05 Billion0.63%
2022 -HK$3.03 Billion2.81%
2021 -HK$2.95 Billion10.58%
2020 -HK$2.67 Billion-18.41%
2019 -HK$3.27 Billion15.72%
2018 -HK$2.82 Billion12.99%
2017 -HK$2.5 Billion59.61%
2016 -HK$1.57 Billion69.32%
2015 -HK$0.93 Billion119.28%
2014 -HK$0.43 Billion39.22%
2013 -HK$0.31 Billion69.1%
2012 -HK$0.18 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Xencor
XNCR
-HK$1.08 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$6.79 B-283.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.19 B-2,592.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$5.28 B-242.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$72.52 B-2,060.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Eli Lilly
LLY
HK$175.05 B-4,831.71%๐Ÿ‡บ๐Ÿ‡ธ USA